UMPJE Pharmacy Law Pass Rate, Format & Study Guide

The Uniform Multistate Pharmacy Jurisprudence Exam (UMPJE) is administered by the National Association of Boards of Pharmacy (NABP), the organization that has coordinated pharmacy regulatory standards across US state boards of pharmacy for over a century. UMPJE is a genuinely new development: NABP began rolling it out to early-adopter jurisdictions in April 2026, with broader adoption from June 2026, as a replacement for the older, fully state-specific MPJE format that required a pharmacist to take an entirely separate, differently-formatted law exam for each individual state where they sought licensure. UMPJE's purpose is to create one shared, national pharmacy-law exam core that participating states adopt, dramatically simplifying the process for pharmacists seeking licensure in multiple states — while jurisdictions that haven't yet adopted UMPJE continue using the older state-specific MPJE format during this transition period.

Pharmacist licensure legally requires passing a jurisprudence exam validating knowledge of pharmacy law in each state where a pharmacist practices, and the old state-by-state MPJE system created real friction for pharmacists working across state lines or relocating — each state's exam tested different, state-specific content requiring separate study and separate fees. UMPJE directly addresses that friction for participating jurisdictions, and as adoption expands through 2026, it stands to meaningfully reduce the licensing burden for pharmacists pursuing multi-state practice, telehealth pharmacy work, or relocation — a genuine structural improvement to how pharmacy licensure portability works, not just a rebrand of the existing MPJE.

This exam is for PharmD graduates entering practice for the first time and pursuing licensure in a state that has adopted the Uniform MPJE, as well as already-licensed pharmacists seeking licensure in an additional participating jurisdiction. Because adoption is still expanding through 2026, candidates should confirm whether their specific target state has adopted UMPJE or still requires the older state-specific MPJE before assuming this guide's content applies directly to their licensing pathway.

The certifying body does not publicly publish an official pass rate for this exam. Be wary of third-party sites citing a specific number here — treat any pass-rate claim you see elsewhere for this exam as unverified.

You must wait at least 30 days after a failed attempt before retaking the MPJE/UMPJE, and you'll need to reapply and pay the exam fees again — some jurisdictions require a longer wait, so confirm with your specific state board. NABP caps candidates at 5 attempts per jurisdiction unless that jurisdiction's board of pharmacy sets a different limit.

Since 2021, NABP has reported the MPJE/UMPJE as a straight Pass or Fail — no numeric or scaled score is given even to candidates who pass. Candidates who don't pass receive a performance report broken down by competency area, so you know specifically where to focus before reapplying.

The exam runs 120 questions total (100 scored, 20 unscored — indistinguishable to the candidate) over a 180-minute (3-hour) appointment, using single-answer multiple-choice questions with only 3 answer options per question — a deliberate format change from the older state-specific MPJE, which used 4-5 answer options. NABP has reported MPJE/UMPJE results as a straight Pass or Fail since 2021, with no numeric score disclosed even to candidates who pass.

UMPJE content covers pharmacy jurisprudence broadly: federal pharmacy law (controlled substances regulation, DEA requirements, FDA regulations relevant to pharmacy practice) plus the shared multistate legal and regulatory framework NABP built the Uniform exam around for participating jurisdictions. NABP does not publish a percentage-weighted content breakdown by domain, and doesn't disclose a numeric score even to passing candidates, so candidates should prepare from NABP's own official UMPJE content outline and the practice exam NABP has published specifically to support the new Uniform format, rather than relying on older state-specific MPJE study guides that may no longer accurately reflect UMPJE's shared content.

UMPJE is required for pharmacist licensure specifically in the jurisdictions that have adopted it — as of the current rollout, the early-adopter states are Arizona, Iowa, Kansas, North Carolina, Ohio, and Rhode Island, with NABP now listing 12 UMPJE participating states overall including Florida, Maryland, Montana, Nebraska, Washington, and West Virginia alongside the six early adopters. It's taken by PharmD graduates entering practice for the first time and by already-licensed pharmacists seeking licensure in an additional participating jurisdiction; candidates targeting a state that hasn't yet adopted UMPJE should confirm with that state's board of pharmacy whether the older state-specific MPJE is still required instead.

The total cost is $450, made up of a $100 nonrefundable exam application fee and a $350 exam fee. Candidates who want to transfer a passing UMPJE score to another participating jurisdiction (rather than retesting for that second state) pay an additional $105 per jurisdiction — a real, structural cost savings compared to the old MPJE system, which effectively required a full separate exam fee for every additional state a pharmacist sought licensure in.

UMPJE, like the MPJE it's replacing, is a licensure examination rather than a renewable certification — there's no periodic recertification or continuing-education requirement tied to the exam itself. Ongoing pharmacist licensure maintenance (continuing education hours, license renewal fees) is governed separately by each state board of pharmacy under its own general pharmacist-licensure renewal rules, distinct from and not tied back to this jurisprudence exam specifically.

120 questions (100 scored) in 180 minutes works out to roughly 1.5 minutes per question, and — unlike the older state-specific MPJE's 4-5 option format — the Uniform MPJE uses 3-option multiple choice throughout, which changes the guessing math worth knowing before test day. Most PharmD candidates start law-specific review in their final semester, layering 3-4 focused weeks on top of coursework; pharmacists relicensing in an additional state often need less time if they've sat for a jurisprudence exam before, but should still budget 2-3 weeks given how state-specific pharmacy law content remains even within the new Uniform framework.

UMPJE is itself the major, currently-unfolding update in this space: NABP's rollout began with early-adopter jurisdictions in April 2026 and expanded to broader adoption from June 2026, with the specific list of participating states still growing as more jurisdictions come on board. Candidates should check NABP's current UMPJE Participating States page directly before assuming their target state has adopted the Uniform format, since this list is actively expanding rather than fixed, and confirm which format (Uniform or the older state-specific MPJE) applies to their specific licensing situation as of whenever they're actually applying.